Abstract:Objective To investigate the clinical risk factors related to the cirrhosis development in patients with hepatitis B virus infection. Methods A total of 988 participants with hepatitis B virus infection were collected for this study in Zhong Shan Hospital affiliated with Fu Dan University between January 2009 and January 2011. All of them were Chinese Han nationality from Shanghai and its surrounding area. Their information, including hepatitis history, serum test, liver imaging, and liver histology if available, were collected. They were divided into healthy recovered and chronic hepatitis group, the later was subdivided into cirrhotic group and non-cirrhotic group. The general informations and clinical determination datas were compared with statistical analysis by using SPSS 18.0 and STATA 11.0 software. Results (1) The ratio of male/female participants was 736/252, and the average age was 50.8±13.2. The numbers of participants in healthy recovered group, non-cirrhotic chronic hepatitis and cirrhotic group were 274, 285, and 429, respectively, and the average ages were 56.7±13.6, 49.2±11.5, and 47.5±13.5, respectively. Chronic hopatitis B (CHB) familial history was found in 2.2% participants of the healthy recovered group and 47.5% participants of chronic hepatitis group. The vertical infection rates were 56.3% in healthy recovered group, and 93.7% in chronic hepatitis group, which have significant difference between them. For chronic hepatitis group, the vertical rates of non-cirrhotic and cirrhotic group were 89.4% and 96.4%, respectively, which also have significant difference between them. The vertical infection was a risk factor for chronicity of hepatitis B (OR=15.02, 95% CI:9.57-23.94) and the development of cirrhosis (OR=3.15, 95%CI:1.39-7.45). The duration of disease of cirrhotic patients (44.1±9.5 years) was longer than that of non-cirrhotic CHB patients (39.3±9.8 years). The ratio of male patients in cirrhotic group was also significantly higher than that in non-cirrhotic group (70.2%) and the duration of disease for male patients (41.7±9.3 years) were shorter than that of female patients (45.0±11.4 years).(2) The levels of liver function rests were significantly different among healthy recover, non-cirrhotic, and cirrhotic group of CHB patients. There were negative correlation between HBsAg and HBV DNA in HBeAg positive patients (r=-0.43);However positive correlation in HBeAg negative patients (r=0.23) was observed. HBsAg level, which was higher than 1 000 COI, of cirrhotic patients (89.5%) was significant higher than that of non-cirrhotic patients (89.5%) (OR=1.86, 95% CI:1.18-2.94). No correlation was found betweem HBV DNA level and the duration of disease of CHB (P=0.21). Although HBV DNA level in cirrhotic group was significantly higher than that in non-cirrhotic group (2.875±2.68 log10copies/mL), the ratio of patients with HBV DNA level, which was higher than 5 log10copies/mL in cirrhotic group (31%) was significantly lower than that in non-cirrhotic group(57.2%). Conclusion The factors associated with cirrhosis development in CHB patients include duration of diseases, familial history, route of infection (vertical infection), male gender, the level of HBsAg(higher than 1 000 COI), and HBV DNA level.

Risk and Predictors of Mortality Associated With Chronic Hepatitis B Infection

Lower Testosterone Levels Predict Increasing Severity and Worse Outcomes of Hepatitis B Virus-Related Acute-on-chronic Liver Failure in Males

Causes of death in people with chronic HBV infection: A population-based cohort study

A Novel Nomogram to Predict 90-Day Mortality in Patients with Hepatitis B Virus-Related Acute-on-chronic Liver Failure: a Single-Center Retrospective Study

Chronic hepatitis B virus infection and total and cause-specific mortality: a prospective cohort study of 0.5 million people

Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark

Extrahepatic Malignancies Are the Leading Cause of Death in Patients with Chronic Hepatitis B without Cirrhosis: A Large Population-Based Cohort Study

Prognosis Prediction Performs Better in Patients with Non-Cirrhosis Hepatitis B Virus-Related Acute-on-chronic Liver Failure Than Those with Cirrhosis.

Circulating Proteomic Panels For Diagnosis And Risk Stratification Of Acute-On-Chronic Liver Failure In Patients With Viral Hepatitis B

Chronic hepatitis B: a long-term retrospective cohort study of disease progression in Shanghai, China.

Evaluation of the clinical risk factors associated with liver cirrhosis in patients with chronic hepatitis B viral infection

HBeAg Negativity is Associated with a Higher Risk of Liver-Related Death in Patients with Chronic Hepatitis B Related Liver Cirrhosis

Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study

Predictive Risk Factors and Scoring Systems Associated with the Development of Hepatocellular Carcinoma in Chronic Hepatitis B

Complications Constitute a Major Risk Factor for Mortality in Hepatitis B Virus-Related Acute-on-chronic Liver Failure Patients: a Multi-National Study from the Asia–Pacific Region

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

Sex-modified Effect of Hepatitis B Virus Infection on Mortality from Primary Liver Cancer.

Clinical Features and Survival in Chinese Patients with Hepatitis B E Antigen-Negative Hepatitis B Virus-Related Cirrhosis

Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy

A Longitudinal Analysis of Mortality Related to Chronic Viral Hepatitis and Hepatocellular Carcinoma in the United States

Risk factors for underlying comorbidities and complications in patients with hepatitis B virus-related acute-on-chronic liver failure